How is mitral valve myxomatous degeneration treated?
Feb 04, 2024
Source: Cainiu Health
Dr. Yang Ziqi
Introduction
In general, mitral valve myxomatous degeneration may be caused by factors such as aging, myocardial ischemia, systemic lupus erythematosus, rheumatic heart disease, and coronary atherosclerotic heart disease. It is recommended to seek medical attention promptly, identify the underlying cause, and receive symptomatic treatment under the guidance of a qualified physician. In daily life, maintain healthy lifestyle habits and avoid consuming spicy or irritating foods.
In general, mitral valve myxomatous degeneration may be caused by factors such as aging, myocardial ischemia, systemic lupus erythematosus, rheumatic heart disease, and coronary atherosclerotic heart disease. It is recommended to seek timely medical attention, identify the underlying cause, and receive symptomatic treatment under the guidance of a qualified physician. Specific analyses are as follows:
1. Aging
With increasing age, various organs in the body gradually undergo aging processes. Valve tissues may progressively degenerate and harden, leading to weakened valve function and eventually developing into myxomatous degeneration. This is considered a normal physiological phenomenon and typically does not require special treatment. Adequate rest and avoidance of excessive fatigue are recommended in daily life.
2. Myocardial Ischemia
Myocardial ischemia is primarily caused by coronary artery narrowing, spasms, or embolism, which may impair cardiac blood circulation and subsequently lead to mitral valve myxomatous degeneration. Patients may also experience symptoms such as chest tightness and palpitations. Treatment may include medications such as isosorbide nitrate tablets, enteric-coated aspirin tablets, and verapamil hydrochloride tablets, as prescribed by a physician.
3. Systemic Lupus Erythematosus
Systemic lupus erythematosus, triggered by genetic factors, viral infections, or immune system abnormalities, may cause the immune system to attack heart valves, resulting in inflammation and tissue damage that can lead to myxomatous degeneration of the mitral valve. Additional symptoms may include generalized fatigue and weight loss. Under medical supervision, medications such as hydroxychloroquine sulfate tablets, azathioprine tablets, and prednisone acetate tablets may be used to help alleviate symptoms.
4. Rheumatic Heart Disease
Rheumatic heart disease is an immune-mediated condition caused by streptococcal infection. The immune system attacks the heart valves, potentially causing inflammation and ultimately leading to mitral valve myxomatous degeneration. Symptoms may include palpitations, shortness of breath, and dyspnea. Medications such as erythromycin tablets, azithromycin tablets, and warfarin sodium tablets may be used as directed by a physician to relieve symptoms.
5. Coronary Atherosclerotic Heart Disease
Coronary atherosclerotic heart disease results from stenosis or occlusion of the coronary arteries. Patients may experience angina pectoris or heart failure, and valve damage may occur, leading to mitral valve myxomatous degeneration. Under medical guidance, medications such as simvastatin dispersible tablets, atorvastatin calcium tablets, and bisoprolol fumarate tablets may be used to manage the condition.
Maintaining healthy lifestyle habits is important. Avoid consuming spicy and irritating foods such as Sichuan pepper, chili peppers, and garlic, as these may hinder recovery.
